Glycation of HDL Polymerizes Apolipoprotein M and Attenuates Its Capacity to Bind to Sphingosine 1-Phosphate.


Journal

Journal of atherosclerosis and thrombosis
ISSN: 1880-3873
Titre abrégé: J Atheroscler Thromb
Pays: Japan
ID NLM: 9506298

Informations de publication

Date de publication:
01 Jul 2021
Historique:
pubmed: 2 10 2020
medline: 15 12 2021
entrez: 1 10 2020
Statut: ppublish

Résumé

Recently, it has been established that most of the pleiotropic effects of high-density lipoprotein (HDL) are attributed to sphingosine 1-phosphate (S1P), which rides on HDL via apolipoprotein M (ApoM). In subjects with diabetes mellitus, both the pleiotropic effects of HDL and its role in reverse cholesterol transport are reported to be impaired. To elucidate the mechanisms underlying the impaired pleiotropic effects of HDL in subjects with diabetes, from the aspects of S1P and ApoM. The incubation of HDL in a high-glucose condition resulted in the dimerization of ApoM. Moreover, the treatment of HDL with methylglyoxal resulted in the modulation of the ApoM structure, as suggested by the results of western blot analysis, isoelectric focusing electrophoresis, and two-dimensional gel electrophoresis, which was reversed by treatment with anti-glycation reagents. The glycation of HDL resulted in impaired binding of the glycated HDL to S1P, and the S1P on glycated HDL degraded faster. In the case of human subjects, on the other hand, although both the serum ApoM levels and the ApoM content in HDL were lower in subjects with diabetes, we did not observe the polymerization of ApoM. Modulation of the quantity and quality of ApoM might explain, at least in part, the impaired functions of HDL in subjects with diabetes mellitus. ApoM might be a useful target for laboratory testing and/or the treatment of diabetes mellitus.

Identifiants

pubmed: 32999208
doi: 10.5551/jat.55699
pmc: PMC8265924
doi:

Substances chimiques

Apolipoproteins M 0
Lipoproteins, HDL 0
Lysophospholipids 0
glycated lipoproteins, HDL 0
sphingosine 1-phosphate 26993-30-6
Sphingosine NGZ37HRE42

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

730-741

Références

Metabolism. 2014 Mar;63(3):307-11
pubmed: 24360750
Atherosclerosis. 2009 Aug;205(2):590-4
pubmed: 19185865
Thromb Haemost. 2018 Jun;118(6):1021-1035
pubmed: 29669385
Biochim Biophys Acta. 2014 Sep;1841(9):1217-26
pubmed: 24814049
Nutr Metab Cardiovasc Dis. 2014 Nov;24(11):1174-80
pubmed: 24984825
J Biol Chem. 2014 Jan 31;289(5):2801-14
pubmed: 24318881
Biochem J. 2018 Jun 21;475(12):2009-2024
pubmed: 29712716
Clin Chim Acta. 2013 Oct 21;425:64-76
pubmed: 23891854
J Clin Endocrinol Metab. 2011 May;96(5):1246-57
pubmed: 21389140
Arthritis Rheumatol. 2018 Nov;70(11):1879-1889
pubmed: 29781582
Endocr Rev. 2006 May;27(3):242-59
pubmed: 16492903
Nature. 1996 Jun 27;381(6585):800-3
pubmed: 8657285
J Atheroscler Thromb. 2017 Sep 1;24(9):954-969
pubmed: 28321011
J Clin Lipidol. 2017 May - Jun;11(3):712-724.e5
pubmed: 28442299
Sci Signal. 2017 Aug 15;10(492):
pubmed: 28811382
Diabetes. 2020 May;69(5):867-881
pubmed: 31915150
Biochim Biophys Acta. 2007 Jul;1771(7):879-82
pubmed: 17556016
J Atheroscler Thromb. 2018 Jan 1;25(1):16-26
pubmed: 28724841
Lipids Health Dis. 2016 Sep 15;15(1):158
pubmed: 27633510
Sci Signal. 2015 Aug 11;8(389):ra79
pubmed: 26268607
Nutr Diabetes. 2014 Sep 01;4:e134
pubmed: 25177914
Biochim Biophys Acta. 2002 May 23;1582(1-3):132-7
pubmed: 12069820
Sci Rep. 2016 Aug 01;6:30655
pubmed: 27476912
Br J Pharmacol. 2016 Jan;173(1):222-33
pubmed: 26445217
Proc Natl Acad Sci U S A. 2011 Jun 7;108(23):9613-8
pubmed: 21606363
Cardiovasc Diabetol. 2017 Oct 12;16(1):132
pubmed: 29025405
J Am Soc Nephrol. 2005 May;16(5):1471-85
pubmed: 15800128
J Diabetes Investig. 2014 Nov;5(6):639-48
pubmed: 25422763
Arterioscler Thromb Vasc Biol. 2016 May;36(5):817-24
pubmed: 26966278
Atherosclerosis. 2013 Jul;229(1):102-9
pubmed: 23664237
J Intern Med. 2009 Sep;266(3):258-67
pubmed: 19457058
Diabetes Res Clin Pract. 2005 Jan;67(1):3-21
pubmed: 15620429
J Lipid Res. 2014 Sep;55(9):1839-46
pubmed: 24474820
Diabetes. 2011 Oct;60(10):2617-23
pubmed: 21852676
J Biol Chem. 2015 Jan 23;290(4):2477-88
pubmed: 25505264
Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):506-514
pubmed: 28126827
FASEB J. 2016 Jun;30(6):2351-9
pubmed: 26956418
FASEB J. 2019 Apr;33(4):5181-5195
pubmed: 30629456
J Lipid Res. 2012 Oct;53(10):2198-2204
pubmed: 22826357
J Biol Chem. 2012 Dec 28;287(53):44645-53
pubmed: 23135269
Biochim Biophys Acta. 2005 May 15;1734(2):198-202
pubmed: 15904876
Nature. 2015 Jul 16;523(7560):342-6
pubmed: 26053123

Auteurs

Tamaki Kobayashi (T)

Department of Clinical Laboratory Medicine, The University of Tokyo.
Analytical Laboratory Chemistry, Graduate School of Health Care Sciences, Tokyo Medical and Dental University.

Makoto Kurano (M)

Department of Clinical Laboratory Medicine, The University of Tokyo.

Mai Nanya (M)

Department of Clinical Laboratory Medicine, The University of Tokyo.

Tomo Shimizu (T)

Research and Development Division, Tsukuba Research Institute, Sekisui Medical Co., Ltd.

Ryunosuke Ohkawa (R)

Analytical Laboratory Chemistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University.

Minoru Tozuka (M)

Life Science Research Center, Nagano Children's Hospital.

Yutaka Yatomi (Y)

Department of Clinical Laboratory Medicine, The University of Tokyo.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH